Proteome-wide identification of HtrA2/Omi substrates

Journal of Proteome Research

Volumn 6, Issue 3, 2007, Pages 1006-1015

  Vande Walle, Lieselotte ^a,b   Van Damme, Petra ^a,b   Lamkanfi, Mohamed ^a,b,d   Saelens, Xavier ^a,b   Vandekerckhove, Joël ^a,b   Gevaert, Kris ^a,b   Vandenabeele, Peter ^a,b,c  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c University of Michigan Medical School ^*  (Belgium)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; COFRADIC; HtrA2; Omi; Substrate

Indexed keywords

CYTOSKELETON PROTEIN; MUTANT PROTEIN; RECOMBINANT PROTEIN; SERINE PROTEINASE OMI;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MASS SPECTROMETER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN PURIFICATION; PROTEOMICS;

APOPTOSIS; CYTOSKELETAL PROTEINS; HUMANS; JURKAT CELLS; MASS SPECTROMETRY; MITOCHONDRIAL PROTEINS; MUTATION, MISSENSE; PEPTIDE FRAGMENTS; PROTEOME; PROTEOMICS; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY;

EID: 33947607164     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr060510d     Document Type: Article

References (52)

1. Hegde, R.; Srinivasula, S. M.; Zhang, Z.; Wassell, R.; Mukattash, R.; Cilenti, L.; DuBois, G.; Lazebnik, Y.; Zervos, A. S.; Fernandes-Alnemri, T.; Alnemri, E. S. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 2002, 277 (1), 432-438.
2. Martins, L. M.; Iaccarino, I.; Tenev, T.; Gschmeissner, S.; Totty, N. F.; Lemoine, N. R.; Savopoulos, J.; Gray, C. W.; Creasy, C. L.; Dingwall, C.; Downward, J. The serine protease Omi/HtrA2 regulates apoptosis by binding XIAP through a reaper-like motif. J. Biol. Chem. 2002, 277 (1), 439-444.
3. Clausen, T.; Southan, C.; Ehrmann, M. The HtrA family of proteases: implications for protein composition and cell fate. Mol. Cell 2002, 10 (3), 443-455.
4. Li, W.; Srinivasula, S. M.; Chai, J.; Li, P.; Wu, J. W.; Zhang, Z.; Alnemri, E. S.; Shi, Y. Structural insights into the pro-apoptotic function of mitochondrial serine protease HtrA2/Omi. Nat. Struct. Biol. 2002, 9 (6), 436-441.
5. Krojer, T.; Garrido-Franco, M.; Huber, R.; Ehrmann, M.; Clausen, T. Crystal structure of DegP (HtrA) reveals a new protease-chaperone machine. Nature 2002, 416 (6879), 455-459.
6. Lipinska, B.; Zylicz, M.; Georgopoulos, C. The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase. J. Bacteriol. 1990, 172 (4), 1791-1797.
7. Skorko-Glonek, J.; Zurawa, D.; Kuczwara, E.; Wozniak, M.; Wypych, Z.; Lipinska, B. The Escherichia coli heat shock protease HtrA participates in defense against oxidative stress. Mol. Gen. Genet. 1999, 262 (2), 342-350.
8. Spiess, C.; Beil, A.; Ehrmann, M. A temperature-dependent switch from chaperone to protease in a widely conserved heat shock protein. Cell 1999, 97 (3), 339-347.
9. Gray, C. W.; Ward, R. V.; Karran, E.; Turconi, S.; Rowles, A.; Viglienghi, D.; Southan, C.; Barton, A.; Fantom, K. G.; West, A.; Savopoulos, J.; Hassan, N. J.; Clinkenbeard, H.; Harming, C.; Amegadzie, B.; Davis, J. B.; Dingwall, C.; Livi, G. P.; Creasy, C. L. Characterization of human HtrA2, a novel serine protease involved in the mammalian cellular stress response. Eur. J. Biochem. 2000, 267 (18), 5699-5710.
10. Martins, L. M.; Turk, B. E.; Cowling, V.; Borg, A.; Jarrell, E. T.; Cantley, L. C.; Downward, J. Binding specificity and regulation of the serine protease and PDZ domains of HtrA2/Omi. J. Biol. Chem. 2003, 278 (49), 49417-49427.
11. Martins, L. M.; Morrison, A.; Klupsch, K.; Fedele, V.; Moisoi, N.; Teismann, P.; Abuin, A.; Grau, E.; Geppert, M.; Livi, G. P.; Creasy, C. L.; Martin, A.; Hargreaves, I.; Heales, S. J.; Okada, H.; Brandner, S.; Schulz, J. B.; Mak, T.; Downward, J. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell. Biol. 2004, 24 (22), 9848-9862.
12. Jones, J. M.; Datta, P.; Srinivasula, S. M.; Ji, W.; Gupta, S.; Zhang, Z.; Davies, E.; Hajnoczky, G.; Saunders, T. L.; Van Keuren, M. L.; Fernandes-Alnemri, T.; Meisler, M. H.; Alnemri, E. S. Loss of Omi mitochondrial protease activity causes the neuromuscular disorder of mnd2 mutant mice. Nature 2003, 425 (6959), 721-727.
13. Strauss, K. M.; Martins, L. M.; Plun-Favreau, H.; Marx, F. P.; Kautzmann, S.; Berg, D.; Gasser, T.; Wszolek, Z.; Muller, T.; Bornemann, A.; Wolburg, H.; Downward, J.; Riess, O.; Schulz, J. B.; Kruger, R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 2005, 14 (15), 2099-2111.
14. Lamkanfi, M.; Declercq, W.; Depuydt, B.; Kalai, M.; Saelens, X.; Vandenabeele, P. The caspase family. In Caspases - Their Role in Cell Death and Cell Survival; Los, M., Walczak, H. (Eds); Landes Bioscience and Kluwer Academic: New York, 2003; pp 1-40.
15. Saelens, X.; Festjens, N.; Vande Walle, L.; van Gurp, M.; van Loo, G.; Vandenabeele, P. Toxic proteins released from mitochondria in cell death. Oncogene 2004, 23 (16), 2861-2874.
16. Lamkanfi, M.; Declercq, W.; Kalai, M.; Saelens, X.; Vandenabeele, P. Alice in caspase land. A phylogenetic analysis of caspases from worm to man. Cell Death Differ. 2002, 9 (4), 358-261.
17. Kim, R.; Emi, M.; Tanabe, K. Caspase-dependent and -independent cell death pathways after DNA damage (Review). Oncol. Rep. 2005, 14 (3), 595-599.
18. Broker, L. E.; Kruyt, F. A.; Giaccone, G. Cell death independent of caspases: a review. Clin. Cancer Res. 2005, 11 (9), 3155-3162.
19. Cilenti, L.; Kyriazis, G. A.; Soundarapandian, M. M.; Stratico, V.; Yerkes, A.; Park, K. M.; Sheridan, A. M.; Alnemri, E. S.; Bonventre, J. V.; Zervos, A. S. Omi/HtrA2 protease mediates cisplatin-induced cell death in renal cells. Am. J. Physiol 2005, 288 (2), F371-379.
20. Kuninaka, S.; Nomura, M.; Hirota, T.; Iida, S.; Hara, T.; Honda, S.; Kunitoku, N.; Sasayama, T.; Arima, Y.; Marumoto, T.; Koja, K.; Yonehara, S.; Saya, H. The tumor suppressor WARTS activates the Omi/HtrA2-dependent pathway of cell death. Oncogene 2005, 24 (34), 5287-5298.
21. Yang, Q. H.; Church-Hajduk, R.; Ren, J.; Newton, M. L.; Du, C. Omi/HtrA2 catalytic cleavage of inhibitor of apoptosis (IAP) irreversibly inactivates IAPs and facilitates caspase activity in apoptosis. Genes Dev. 2003, 17 (12), 1487-1496.
22. Suzuki, Y.; Imai, Y.; Nakayama, H.; Takahashi, K.; Takio, K.; Takahashi, R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol. Cell 2001, 8 (3), 613-621.
23. Verhagen, A. M.; Silke, J.; Ekert, P. G.; Pakusch, M.; Kaufmann, H.; Connolly, L. M.; Day, C. L.; Tikoo, A.; Burke, R.; Wrobel, C.; Moritz, R. L.; Simpson, R. J.; Vaux, D. L. HtrA2 promotes cell death through its serine protease activity and its ability to antagonize inhibitor of apoptosis proteins. J. Biol. Chem. 2002, 277 (1), 445-454.
24. van Loo, G.; van Gurp, M.; Depuydt, B.; Srinivasula, S. M.; Rodriguez, I.; Alnemri, E. S.; Gevaert, K.; Vandekerckhove, J.; Declercq, W.; Vandenabeele, P. The serine protease Omi/HtrA2 is released from mitochondria during apoptosis. Omi interacts with caspase-inhibitor XIAP and induces enhanced caspase activity. Cell Death Differ. 2002, 9 (1), 20-26.
25. Sekine, K.; Hao, Y.; Suzuki, Y.; Takahashi, R.; Tsuruo, T.; Naito, M. HtrA2 cleaves Apollon and induces cell death by IAP-binding motif in Apollon-deficient cells. Biochem. Biophys. Res. Commun. 2005, 330 (1), 279-285.
26. Srinivasula, S. M.; Gupta, S.; Datta, P.; Zhang, Z.; Hegde, R.; Cheong, N.; Fernandes-Alnemri, T.; Alnemri, E. S. Inhibitor of apoptosis proteins are substrates for the mitochondrial serine protease Omi/HtrA2. J. Biol. Chem. 2003, 278 (34), 31469-31472.
27. Suzuki, Y.; Takahashi-Niki, K.; Akagi, T.; Hashikawa, T.; Takahashi, R. Mitochondrial protease Omi/HtrA2 enhances caspase activation through multiple pathways. Cell Death Differ. 2004, 11 (2), 208-216.
28. Liu, Z.; Li, H.; Derouet, M.; Berezkin, A.; Sasazuki, T.; Shirasawa, S.; Rosen, K. Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm. J. Biol. Chem. 2006, 281 (21), 14738-14747.
29. Cilenti, L.; Lee, Y.; Hess, S.; Srinivasula, S.; Park, K. M.; Junqueira, D.; Davis, H.; Bonventre, J. V.; Alnemri, E. S.; Zervos, A. S. Characterization of a novel and specific inhibitor for the proapoptotic protease Omi/HtrA2. J. Biol. Chem. 2003, 278 (13), 11489-11494.
30. Blink, E.; Maianski, N. A.; Alnemri, E. S.; Zervos, A. S.; Roos, D.; Kuijpers, T. W. Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils. Cell Death Differ. 2004, 11 (8), 937-939.
31. Trencia, A.; Fiory, F.; Maitan, M. A.; Vito, P.; Barbagallo, A. P.; Perfetti, A.; Miele, C.; Ungaro, P.; Oriente, F.; Cilenti, L.; Zervos, A. S.; Formisano, P.; Beguinot, F. Omi/HtrA2 promotes cell death by binding and degrading the anti-apoptotic protein ped/pea- 15. J. Biol. Chem. 2004, 279 (45), 46566-46572.
32. Cilenti, L.; Soundarapandian, M. M.; Kyriazis, G. A.; Stratico, V.; Singh, S.; Gupta, S.; Bonventre, J. V.; Alnemri, E. S.; Zervos, A. S. Regulation of HAX-1 anti-apoptotic protein by Omi/HtrA2 protease during cell death. J. Biol. Chem. 2004, 279 (48), 50295-50301.
33. Liu, H. R.; Gao, E.; Hu, A.; Tao, L.; Qu, Y.; Most, P.; Koch, W. J.; Christopher, T. A.; Lopez, B. L.; Alnemri, E. S.; Zervos, A. S.; Ma, X. L. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Circulation 2005, 111 (1), 90-96.
34. Goffredo, D.; Rigamonti, D.; Zuccato, C.; Tartari, M.; Valenza, M.; Cattaneo, E. Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease. Pharmacol. Res. 2005, 52 (2), 140-150.
35. Klupsch, K.; Downward, J. The protease inhibitor Ucf-101 induces cellular responses independently of its known target, HtrA2/Omi. Cell Death Differ. 2006, 13 (12), 2157-2159.
36. Van Damme, P.; Martens, L.; Van Damme, J.; Hugelier, K.; Staes, A.; Vandekerckhove, J.; Gevaert, K. Caspase-specific and non-specific in vivo protein processing during Fas-induced apoptosis. Nat. Methods 2005, 2 (10), 771-777.
37. Mertens, N.; Remaut, E.; Fiers, W. Versatile, multi-featured plasmids for high-level expression of heterologous genes in Escherichia coli: overproduction of human and murine cytokines. Gene 1995, 164 (1), 9-15.
38. Faccio, L.; Fusco, C.; Chen, A.; Martinotti, S.; Bonventre, J. V.; Zervos, A. S. Characterization of a novel human serine protease that has extensive homology to bacterial heat shock endoprotease HtrA and is regulated by kidney ischemia. J. Biol. Chem. 2000, 275 (4), 2581-2588.
39. Harvey, N. L.; Butt, A. J.; Kumar, S. Functional activation of Nedd2/ICH-1 (caspase-2) is an early process in apoptosis. J. Biol. Chem. 1997, 272 (20), 13134-13139.
40. Tinel, A.; Tschopp, J. The PIDDosome, a protein complex implicated in activation of caspase-2 in response to genotoxic stress. Science 2004, 304 (5672), 843-846.
41. Perkins, D. N.; Pappin, D. J.; Creasy, D. M.; Cottrell, J. S. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999, 20 (18), 3551-3567.
42. Hamaguchi, M.; Meth, J. L.; von Klitzing, C.; Wei, W.; Esposito, D.; Rodgers, L.; Walsh, T.; Welcsh, P.; King, M. C.; Wigler, M. H. DBC2, a candidate for a tumor suppressor gene involved in breast cancer. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (21), 13647-13652.
43. Sundararajan, R.; Chen, G.; Mukherjee, C.; White, E. Caspase-dependent processing activates the proapoptotic activity of deleted in breast cancer-1 during tumor necrosis factor-alpha-mediated death signaling. Oncogene 2005, 24 (31), 4908-4920.
44. Clemens, M. J.; Bushell, M.; Jeffrey, I. W.; Pain, V. M.; Morley, S. J. Translation initiation factor modifications and the regulation of protein synthesis in apoptotic cells. Cell Death Differ. 2000, 7 (7), 603-615.
45. Saelens, X.; Kalai, M.; Vandenabeele, P. Translation inhibition in apoptosis: caspase-dependent PKR activation and eIF2-alpha phosphorylation. J. Biol. Chem. 2001, 276 (45), 41620-41628.
46. Lustbader, J. W.; Cirilli, M.; Lin, C.; Xu, H. W.; Takuma, K.; Wang, N.; Caspersen, C.; Chen, X.; Pollak, S.; Chaney, M.; Trinchese, F.; Liu, S.; Gunn-Moore, F.; Lue, L. F.; Walker, D. G.; Kuppusamy, P.; Zewier, Z. L.; Arancio, O.; Stern, D.; Yan, S. S.; Wu, H. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004, 304 (5669), 448-452.
47. Yan, S. D.; Fu, J.; Soto, C.; Chen, X.; Zhu, H.; Al-Mohanna, F.; Collison, K.; Zhu, A.; Stern, E.; Saido, T.; Tohyama, M.; Ogawa, S.; Roher, A.; Stern, D. An intracellular protein that binds amyloid-beta peptide and mediates neurotoxicity in Alzheimer's disease. Nature 1997, 389 (6652), 689-695.
48. Park, H. J.; Kim, S. S.; Seong, Y. M.; Kim, K. H.; Goo, H. G.; Yoon, E. J.; Min, D. S.; Kang, S.; Rhim, H. Beta-amyloid precursor protein is a direct cleavage target of HtrA2 serine protease: Implications for the physiological function of HtrA2 in the mitochondria. J. Biol. Chem. 2006, 281 (45), 34277-34287.
49. Gupta, S.; Singh, R.; Datta, P.; Zhang, Z.; Orr, C.; Lu, Z.; Dubois, G.; Zervos, A. S.; Meisler, M. H.; Srinivasula, S. M.; Fernandes-Alnemri, T.; Alnemri, E. S. The C-terminal tail of presenilin regulates Omi/HtrA2 protease activity. J. Biol. Chem. 2004, 279 (44), 45844-54584.
50. Breckenridge, D. G.; Nguyen, M.; Kuppig, S.; Reth, M.; Shore, G. C. The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum. Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (7), 4331-4336.
51. Fischer, U.; Janicke, R. U.; Schulze-Osthoff, K. Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ. 2003, 10 (1), 76-100.
52. Kolmar, H.; Waller, P. R.; Sauer, R. T. The DegP and DegQ periplasmic endoproteases of Escherichia coli: specificity for cleavage sites and substrate conformation. J. Bacteriol. 1996, 178 (20), 5925-5929.